Anita Mathias

3.8k total citations
65 papers, 2.6k citations indexed

About

Anita Mathias is a scholar working on Infectious Diseases, Hepatology and Epidemiology. According to data from OpenAlex, Anita Mathias has authored 65 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Infectious Diseases, 26 papers in Hepatology and 18 papers in Epidemiology. Recurrent topics in Anita Mathias's work include HIV/AIDS drug development and treatment (29 papers), Hepatitis C virus research (25 papers) and Liver Disease Diagnosis and Treatment (11 papers). Anita Mathias is often cited by papers focused on HIV/AIDS drug development and treatment (29 papers), Hepatitis C virus research (25 papers) and Liver Disease Diagnosis and Treatment (11 papers). Anita Mathias collaborates with scholars based in United States, China and United Kingdom. Anita Mathias's co-authors include Brian P. Kearney, Polina German, Jashvant D. Unadkat, Brian J. Kirby, William T. Symonds, Jane Hitti, John Ling, Diana M. Brainard, S. Ramanathan and Rita Humeniuk and has published in prestigious journals such as Clinical Infectious Diseases, Analytical Biochemistry and The Journal of Infectious Diseases.

In The Last Decade

Anita Mathias

65 papers receiving 2.5k citations

Peers

Countries citing papers authored by Anita Mathias

Since Specialization

Citations

This map shows the geographic impact of Anita Mathias's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anita Mathias with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anita Mathias more than expected).

Fields of papers citing papers by Anita Mathias

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anita Mathias. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anita Mathias. The network helps show where Anita Mathias may publish in the future.

Co-authorship network of co-authors of Anita Mathias

This figure shows the co-authorship network connecting the top 25 collaborators of Anita Mathias. A scholar is included among the top collaborators of Anita Mathias based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anita Mathias. Anita Mathias is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor 2021 ·Clinical Pharmacokinetics ·Rita Humeniuk, Anita Mathias, Brian J. Kirby, Justin D. Lutz, Huyen Cao, Anu Osinusi, Darius Babusis, Danielle Porter, Xuelian Wei, John Ling, Y. Sunila Reddy, Polina German	93
2	Validation of LC-MS/MS methods for determination of remdesivir and its metabolites GS-441524 and GS-704277 in acidified human plasma and their application in COVID-19 related clinical studies 2021 ·Analytical Biochemistry ·Deqing Xiao, Kah Hiing John Ling, Thomas Tarnowski, Rita Humeniuk, Polina German, Anita Mathias, (unknown), (unknown), (unknown)	43
3	Prediction of Transporter-Mediated Rosuvastatin Hepatic Uptake Clearance and Drug Interaction in Humans Using Proteomics-Informed REF Approach 2020 ·Drug Metabolism and Disposition ·Vineet Kumar, (unknown), Kazuya Ishida, Laurent Salphati, Cornelis E. C. A. Hop, Christopher Rowbottom, Guangqing Xiao, Yurong Lai, Anita Mathias, Xiaoyan Chu, W. Griffith Humphreys, Mingxiang Liao, (unknown), (unknown), Scott Heyward, Jashvant D. Unadkat	27
4	A Comparison of Total and Plasma Membrane Abundance of Transporters in Suspended, Plated, Sandwich-Cultured Human Hepatocytes Versus Human Liver Tissue Using Quantitative Targeted Proteomics and Cell Surface Biotinylation 2019 ·Drug Metabolism and Disposition ·Vineet Kumar, Laurent Salphati, Cornelis E. C. A. Hop, Guangqing Xiao, Yurong Lai, Anita Mathias, Xiaoyan Chu, W. Griffith Humphreys, Mingxiang Liao, Scott Heyward, Jashvant D. Unadkat	38
5	Drug–Drug Interaction Profile of the Fixed-Dose Combination Tablet Regimen Ledipasvir/Sofosbuvir 2018 ·Clinical Pharmacokinetics ·Polina German, Anita Mathias, Diana M. Brainard, Brian P. Kearney	11
6	Abundance of Phase 1 and 2 Drug-Metabolizing Enzymes in Alcoholic and Hepatitis C Cirrhotic Livers: A Quantitative Targeted Proteomics Study 2018 ·Drug Metabolism and Disposition ·Bhagwat Prasad, Deepak Bhatt, Katherine Johnson, (unknown), Xiaoyan Chu, Laurent Salphati, Guangqing Xiao, Caroline Lee, Cornelis E. C. A. Hop, Anita Mathias, Yurong Lai, Mingxiang Liao, W. Griffith Humphreys, Sean Kumer, Jashvant D. Unadkat	72
7	A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection 2016 ·Liver International ·Jia‐Horng Kao, Rong‐Nan Chien, Ting‐Tsung Chang, Cheng‐Yuan Peng, Tsung‐Hui Hu, Gin‐Ho Lo, Horng‐Yuan Wang, (unknown), Jenny C. Yang, Steven Knox, Lingling Han, Hongmei Mo, Anita Mathias, Diana M. Brainard, I‐Shyan Sheen, Yu‐Chun Hsu, Chi‐Jen Chu, Wan‐Long Chuang	22
8	Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of the Hepatitis C Virus NS5B Polymerase Inhibitor Sofosbuvir 2015 ·Clinical Pharmacokinetics ·Brian J. Kirby, William T. Symonds, Brian P. Kearney, Anita Mathias	196
9	Use of Multiple Probes to Assess Transporter- and Cytochrome P450-Mediated Drug–Drug Interaction Potential of the Pangenotypic HCV NS5A Inhibitor Velpatasvir 2015 ·Clinical Pharmacokinetics ·Erik Mogalian, Polina German, Brian P. Kearney, Cheng Yong Yang, Diana M. Brainard, John McNally, Lisa Moorehead, Anita Mathias	41
10	Lack of Drug Interactions Between Boosted and Unboosted Tenofovir Alafenamide-Based Antiretroviral Single Tablet Regimens (Emtricitabine/Rilpivirine/Tenofovir Alafenamide and Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide) and the Anti-HCV Single Tablet Regimen Ledipasvir/Sofosbuvir 2015 ·Open Forum Infectious Diseases ·(unknown), Joseph M. Custodio, Phillip S. Pang, Moupali Das, Huyen Cao, X. Grace, Anita Mathias, (unknown)	5
11	Pharmacokinetics of Once-Daily Boosted Elvitegravir When Administered in Combination With Acid-Reducing Agents 2013 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·S. Ramanathan, Anita Mathias, Xuelian Wei, Gong Shen, Joanna Koziara, Andrew Cheng, Brian P. Kearney	34
12	Effect of Cobicistat on Glomerular Filtration Rate in Subjects With Normal and Impaired Renal Function 2012 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Polina German, Hui C. Liu, Javier Szwarcberg, (unknown), Jessica L. Andrews, Brian P. Kearney, Anita Mathias	133
13	Phase 2 study of cobicistat versus ritonavir each with once-daily atazanavir and fixed-dose emtricitabine/tenofovir df in the initial treatment of HIV infection 2011 ·AIDS ·Richard Elion, Calvin Cohen, Joseph Gathe, Peter Shalit, Trevor Hawkins, Hui C. Liu, Anita Mathias, Steven L. Chuck, Brian P. Kearney, David R. Warren	76
14	Pharmacokinetics and Pharmacodynamics of GS-9350: A Novel Pharmacokinetic Enhancer Without Anti-HIV Activity 2009 ·Clinical Pharmacology & Therapeutics ·Anita Mathias, Polina German, Bernard P. Murray, (unknown), Aakanksha Jain, Steve West, David R. Warren, James Hoi Po Hui, Brian P. Kearney	171
15	Lack of Effect of Tenofovir Disoproxil Fumarate on Pharmacokinetics of Hormonal Contraceptives 2009 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Brian P. Kearney, Anita Mathias	39
16	Effect of Ritonavir-Boosted Tipranavir or Darunavir on the Steady-State Pharmacokinetics of Elvitegravir 2008 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Anita Mathias, John E. Hinkle, Gong Shen, (unknown), Peter J. Piliero, Vanitha Sekar, (unknown), Frank Tomaka, Brian P. Kearney	19
17	Bioequivalence of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen 2007 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Anita Mathias, John E. Hinkle, (unknown), James Hoi Po Hui, Sanjeev Kaul, Brian P. Kearney	38
18	Pharmacokinetics and Safety of Tenofovir Disoproxil Fumarate on Coadministration With Lopinavir/Ritonavir 2006 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Brian P. Kearney, Anita Mathias, (unknown), (unknown), Ramin Ebrahimi, Andrew Cheng	129
19	P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages 2005 ·American Journal of Physiology-Regulatory, Integrative and Comparative Physiology ·Anita Mathias, Jane Hitti, Jashvant D. Unadkat	147
20	Pharmacokinetics and Safety of Stavudine in HIV‐Infected Pregnant Women and Their Infants: Pediatric AIDS Clinical Trials Group Protocol 332 2004 ·The Journal of Infectious Diseases ·Nancy A. Wade, Jashvant D. Unadkat, Sharon Huang, David E. Shapiro, Anita Mathias, Salih Yasin, Gregory Ciupak, (unknown), Isaac Delke, Mobeen H. Rathore, Jane Hitti, Lisa M. Frenkel, Renee Samelson, Mary E. Smith, Lynne Mofenson, Sandra Burchett	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact